Farkas K - Search Results

1

Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease.

Kovács MG, Kovács ZZA, Varga Z, Szűcs G, Freiwan M, Farkas K, Kővári B, Cserni G, Kriston A, Kovács F, Horváth P, Földesi I, Csont T, Kahán Z, Sárközy M. Kovács MG, et al. Among authors: farkas k. Int J Mol Sci. 2021 Nov 30;22(23):12963. doi: 10.3390/ijms222312963. Int J Mol Sci. 2021. PMID: 34884782 Free PMC article.

2

Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.

Kovács ZZA, Szűcs G, Freiwan M, Kovács MG, Márványkövi FM, Dinh H, Siska A, Farkas K, Kovács F, Kriston A, Horváth P, Kővári B, Cserni BG, Cserni G, Földesi I, Csont T, Sárközy M. Kovács ZZA, et al. Among authors: farkas k. Sci Rep. 2021 Sep 1;11(1):17495. doi: 10.1038/s41598-021-96815-5. Sci Rep. 2021. PMID: 34471171 Free PMC article.

3

Polyelectrolyte coating on superparamagnetic iron oxide nanoparticles as interface between magnetic core and biorelevant media.

Tombácz E, Farkas K, Földesi I, Szekeres M, Illés E, Tóth IY, Nesztor D, Szabó T. Tombácz E, et al. Among authors: farkas k. Interface Focus. 2016 Dec 6;6(6):20160068. doi: 10.1098/rsfs.2016.0068. Interface Focus. 2016. PMID: 27920900 Free PMC article.

4

[No title available]

[No authors listed] [No authors listed] PMID: 34617984

5

PEGylation of Superparamagnetic Iron Oxide Nanoparticles with Self-Organizing Polyacrylate-PEG Brushes for Contrast Enhancement in MRI Diagnosis.

Illés E, Szekeres M, Tóth IY, Farkas K, Földesi I, Szabó Á, Iván B, Tombácz E. Illés E, et al. Among authors: farkas k. Nanomaterials (Basel). 2018 Sep 29;8(10):776. doi: 10.3390/nano8100776. Nanomaterials (Basel). 2018. PMID: 30274317 Free PMC article.

6

Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications.

Szekeres M, Tóth IY, Illés E, Hajdú A, Zupkó I, Farkas K, Oszlánczi G, Tiszlavicz L, Tombácz E. Szekeres M, et al. Among authors: farkas k. Int J Mol Sci. 2013 Jul 12;14(7):14550-74. doi: 10.3390/ijms140714550. Int J Mol Sci. 2013. PMID: 23857054 Free PMC article.

7

Commentary: predicting relapse in Crohn's disease patients in remission with biologics - authors' reply.

Molnár T, Farkas K. Molnár T, et al. Among authors: farkas k. Aliment Pharmacol Ther. 2013 Feb;37(4):498. doi: 10.1111/apt.12215. Aliment Pharmacol Ther. 2013. PMID: 23336686 Free article. No abstract available.

8

Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease?

Molnár T, Farkas K, Miheller P, Nyári T, Szepes Z, Herszényi L, Müzes G, Nagy F, Tulassay Z, Wittmann T. Molnár T, et al. Among authors: farkas k. J Crohns Colitis. 2008 Dec;2(4):322-6. doi: 10.1016/j.crohns.2008.07.003. Epub 2008 Nov 11. J Crohns Colitis. 2008. PMID: 21172231

9

Letter: role of diet in the onset and relapse of inflammatory bowel disease from the patients' perspective.

Farkas K, Szepes Z, Nagy F, Bálint A, Bor R, Wittmann T, Molnár T. Farkas K, et al. Aliment Pharmacol Ther. 2014 Feb;39(3):340. doi: 10.1111/apt.12554. Aliment Pharmacol Ther. 2014. PMID: 24397321 Free article. No abstract available.

10

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy.

Molnár T, Lakatos PL, Farkas K, Nagy F, Szepes Z, Miheller P, Horváth G, Papp M, Palatka K, Nyári T, Bálint A, Lőrinczy K, Wittmann T. Molnár T, et al. Among authors: farkas k. Aliment Pharmacol Ther. 2013 Jan;37(2):225-33. doi: 10.1111/apt.12160. Epub 2012 Nov 26. Aliment Pharmacol Ther. 2013. PMID: 23181359 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

562 results

Search Page